Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

5.87
+0.19003.35%
Post-market: 5.890.0200+0.34%19:49 EDT
Volume:2.39M
Turnover:14.00M
Market Cap:300.97M
PE:-1.73
High:5.99
Open:5.59
Low:5.50
Close:5.68
52wk High:14.06
52wk Low:4.36
Shares:51.27M
Float Shares:48.37M
Volume Ratio:2.39
T/O Rate:4.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3870
EPS(LYR):0.9300
ROE:-40.29%
ROA:6.93%
PB:0.88
PE(LYR):6.31

Loading ...

Emergent Biosolutions Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 09

Emergent BioSolutions Repurchases $75 Million of Senior Unsecured Notes Due 2028

MT Newswires Live
·
Sep 03

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes

THOMSON REUTERS
·
Sep 03

Emergent BioSolutions Secures New BARDA Anthrax Contract

TIPRANKS
·
Sep 02

Emergent BioSolutions: Got Contract Modification of Barda Av7909 Contract from Office of Assistant Secretary for Preparedness and Response

THOMSON REUTERS
·
Sep 02

Emergent BioSolutions - Contract Modification for Procurement of Additional Cyfendus (Av7909) Doses - SEC Filing

THOMSON REUTERS
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

Emergent BioSolutions Wins $24 Million BARDA Contract Modification for Cyfendus Anthrax Vaccine Supply

Reuters
·
Sep 01

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for Cyfendus® (Anthrax Vaccine Adsorbed, Adjuvanted)

THOMSON REUTERS
·
Sep 01

Emergent BioSolutions - Awarded Standing Offer to Supply Narcan Nasal Spray in Canada

THOMSON REUTERS
·
Aug 31

Emergent BioSolutions - Standing Offer Effective Oct 1, 2026-Sept 30, 2029 with Two-Year Extension Option

THOMSON REUTERS
·
Aug 31

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day

GlobeNewswire
·
Aug 31

August 2026's Highlighted Stocks That May Be Trading Below Estimated Value

Simply Wall St.
·
Aug 25

Emergent BioSolutions reinstated with an Underweight at JPMorgan

TIPRANKS
·
Aug 21

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Reuters
·
Aug 21

Emergent BioSolutions EVP, Chief Growth Officer Stephanie Duatschek Files Initial Beneficial Ownership Statement

Reuters
·
Aug 12

Emergent Biosolutions is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 10

aTyr Pharma Q2 Net Loss Narrows

Reuters
·
Aug 08

SIGA Technologies Q2 Revenue, Profit Drop as Contract Ends

Reuters
·
Aug 07

INmune Bio Q2 Net Loss Narrows on Lower Impairment Charges

Reuters
·
Aug 07